Search your stocks

Share

Profile

KILITCHKilitch Drugs (India) Ltd.

360(-1.06%)

1W: +0.66%

1M: -16.39%

1Y: -4.64%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Strong revenue growth in the latest quarter, reaching ₹47.48 crore, up from ₹41.20 crore in Q3 2023.
Operating profit margin improved significantly in Q4 2023, indicating better cost management.
Net profit rebounded to ₹8.61 crore in Q4 2023, showcasing a recovery from prior losses.

NEGATIVES

Expenses increased sharply in Q4 2023, rising to ₹42.29 crore, impacting profitability.
Operating profit margin dropped to 10.92% in Q4 2023 from 15.28% in Q3 2023, signaling rising costs.
Net profit declined to ₹1.74 crore in Q3 2023, highlighting volatility in earnings.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		41.20	31.79	44.82	33.45	47.48	56.17	61.23	43.14
Expenses		34.91	31.93	39.99	34.38	42.29	49.64	49.08	42.25
Operating Profit		6.29	-0.13	4.83	-0.92	5.18	6.53	12.15	0.89
Other Income		0.49	2.96	0.47	2.57	5.16	1.73	1.70	2.56
Interest		1.51	1.60	1.32	1.73	0.31	1.40	1.60	1.53
Depreciation		0.82	0.82	0.93	0.85	0.60	0.81	0.85	0.84
Profit Before Tax		6.78	2.82	5.30	1.65	10.35	8.25	13.84	3.45
Tax		1.69	1.08	1.62	1.54	1.73	2.64	3.62	1.19
Net Profit		5.09	1.74	3.68	0.11	8.61	5.62	10.22	2.26
Eps in Rs		2.93	1.85	2.24	0.83	5.36	3.71	6.47	1.88